Market openADR
Smith & Nephew/$SNN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Smith & Nephew
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Ticker
$SNN
Sector
Health Care
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Watford, United Kingdom
Employees
18,000
Website
Smith & Nephew Metrics
BasicAdvanced
$13B
84.69
$0.35
0.58
$0.73
1.85%
Price and volume
Market cap
$13B
Beta
0.58
52-week high
$31.53
52-week low
$28.22
Average daily volume
666K
Dividend rate
$0.73
Financial strength
Current ratio
2.509
Quick ratio
1.107
Long term debt to equity
62.92
Total debt to equity
70.221
Dividend payout ratio (TTM)
107.54%
Interest coverage (TTM)
5.25%
Management effectiveness
Return on assets (TTM)
4.51%
Return on equity (TTM)
5.84%
Valuation
Price to earnings (TTM)
84.691
Price to revenue (TTM)
4.564
Price to book
1.89
Price to tangible book (TTM)
9.96
Price to free cash flow (TTM)
85.556
Dividend yield (TTM)
2.47%
Forward dividend yield
1.85%
Growth
Revenue change (TTM)
5.48%
Earnings per share change (TTM)
39.77%
3-year revenue growth (CAGR)
3.26%
3-year earnings per share growth (CAGR)
-17.85%
What the Analysts think about Smith & Nephew
Analyst Ratings
Majority rating from 4 analysts.
Smith & Nephew Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$2.8B
2.96%
Net income
$91M
-47.09%
Profit margin
3.23%
-48.65%
Smith & Nephew Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 22
Q4 22
Q2 23
Q4 23
Q2 24
Actual
$0.76
$0.88
$0.70
$0.96
-
Expected
$0.80
$0.80
$0.58
$0.74
$0.58
Surprise
5.00%
10.00%
20.34%
29.46%
-
Smith & Nephew News
AllArticlesVideos
Smith & Nephew: Underappreciated Recovery With Strategic Upside
Seeking Alpha·4 days ago
Smith & Nephew falls after downgrade by leading investment bank
Proactive Investors·1 month ago
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market openADR
Upcoming events
May28
Smith & Nephew
Dividend·Payment
$0.462
Per share
FAQs
What’s the current market cap for Smith & Nephew stock?
Smith & Nephew (SNN) has a market cap of $13B as of April 23, 2025.
What is the P/E ratio for Smith & Nephew stock?
The price to earnings (P/E) ratio for Smith & Nephew (SNN) stock is 84.69 as of April 23, 2025.
Does Smith & Nephew stock pay dividends?
Yes, the Smith & Nephew (SNN) stock pays dividends to shareholders. As of April 23, 2025, the dividend rate is $0.73 and the yield is 1.85%. Smith & Nephew has a payout ratio of 107.54% on a trailing twelve-month basis.
When is the next Smith & Nephew dividend payment date?
The next Smith & Nephew (SNN) dividend payment is scheduled for May 28, 2025.
What is the beta indicator for Smith & Nephew?
Smith & Nephew (SNN) has a beta rating of 0.58. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.